X0306 4/A 2016-11-30 2016-12-02 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001323113 Swisher Daniel N JR C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Stock Option (Right to Buy) 4.00 2016-11-30 4 A 0 240000 0 A 2026-11-30 Common Stock 240000 240000 D Twenty-five per cent (25%) of the total shares vest on November 30, 2017 and the remainder will vest ratably on each monthly anniversary thereafter such that the award will be fully vested on November 30, 2020. This amendment is being filed to correct the exercise price of the option grant so that it reflects the adjusted closing price on November 30, 2016 of $4.00. /s/ Daniel N. Swisher, Jr. 2016-12-06